The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced an $8.9 million agreement with Siemens Healthineers, a Tarrytown, New York-based company to further develop a Zika virus test that could expand the nation’s testing capacity for the virus and potentially lead to lower costs for patients.
CARB-X injects up to $48 million to accelerate first Powered by CARB-X portfolio of drug discovery and development projects to tackle antibiotic resistance
3 potential new classes of antibiotics, 4 innovative non-traditional products and 7 new molecular targets against the most urgent deadliest 'superbugs'
Antimicrobial Resistance Diagnostic Challenge selects 10 semifinalists in first phase of competition
Each will receive $50,000 to develop prototypes of diagnostics to improve detection of drug resistant bacteria.